Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache.

OBJECTIVES To investigate the efficacy and long-term outcome of intravenous prochlorperazine for the treatment of refractory chronic daily headache. BACKGROUND Unlike dihydroergotamine, the treatment results of intravenous neuroleptics as first-line agents for refractory chronic daily headache have rarely been reported. METHODS We retrospectively… CONTINUE READING